{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["22(1)"],"submitter":["Tang X"],"pubmed_abstract":["<h4>Background</h4>The prevalence of Helicobacter pylori antibiotic susceptibility in the Tibet Autonomous Region, China is not determined. This study aimed to evaluate the antibiotic resistance patterns of H. pylori isolates there.<h4>Results</h4>A total of 153 (38.5%) H. pylori strains were successfully isolated from 397 patients in People's Hospital of Tibet Autonomous Region, China. The overall resistance rates were as follows: clarithromycin (27.4%), levofloxacin (31.3%), metronidazole (86.2%), amoxicillin (15.6%), tetracycline (0%), furazolidone (0.6%), and rifampicin (73.2%). Only 2.0% of H. pylori isolates were susceptible to all tested antimicrobials, with mono resistance, dual resistance, triple resistance, quadruple resistance, and quintuple resistance being 18.3%, 44.4%, 18.3%,"],"journal":["BMC microbiology"],"pagination":["196"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9375320"],"repository":["biostudies-literature"],"pubmed_title":["Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China."],"pmcid":["PMC9375320"],"pubmed_authors":["Li H","Marshall BJ","Shen Y","Song X","Wang Z","Tang X","Benghezal M","Tang H"],"additional_accession":[]},"is_claimable":false,"name":"Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China.","description":"<h4>Background</h4>The prevalence of Helicobacter pylori antibiotic susceptibility in the Tibet Autonomous Region, China is not determined. This study aimed to evaluate the antibiotic resistance patterns of H. pylori isolates there.<h4>Results</h4>A total of 153 (38.5%) H. pylori strains were successfully isolated from 397 patients in People's Hospital of Tibet Autonomous Region, China. The overall resistance rates were as follows: clarithromycin (27.4%), levofloxacin (31.3%), metronidazole (86.2%), amoxicillin (15.6%), tetracycline (0%), furazolidone (0.6%), and rifampicin (73.2%). Only 2.0% of H. pylori isolates were susceptible to all tested antimicrobials, with mono resistance, dual resistance, triple resistance, quadruple resistance, and quintuple resistance being 18.3%, 44.4%, 18.3%,","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Aug","modification":"2025-04-19T18:51:01.883Z","creation":"2025-04-19T18:51:01.883Z"},"accession":"S-EPMC9375320","cross_references":{"pubmed":["35964011"],"doi":["10.1186/s12866-022-02613-y"]}}